Revolution Medicines Inc.... (RVMDW)
0.04
-0.03 (-46.67%)
At close: Mar 31, 2025, 3:16 PM
0.04
0.00%
After-hours: Mar 31, 2025, 04:00 PM EDT
Revolution Medicines Warrant Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Cash & Equivalents | 543.06M | 696.15M | 161.41M | 108.5M | 104.27M | 16.66M | 69.59M | 9.08M |
| Short-Term Investments | 1.75B | 1.16B | 483.53M | 468.56M | 336.47M | 106.1M | n/a | n/a |
| Long-Term Investments | n/a | n/a | 1.74M | 1.74M | 1.08M | 214K | 214K | n/a |
| Other Long-Term Assets | 17.57M | 10.06M | -23.4M | -14.49M | -19.13M | -8.27M | -2.54M | 383K |
| Receivables | n/a | 1.25M | 4.67M | 5.93M | 6.39M | 8.74M | 7.3M | n/a |
| Inventory | n/a | n/a | 1.00 | -12.72M | n/a | 1.00 | 6.6M | n/a |
| Other Current Assets | 38.33M | 25.07M | 10.57M | 6.79M | 6.99M | 2.49M | 8.54M | 362K |
| Total Current Assets | 2.33B | 1.88B | 660.18M | 577.05M | 454.12M | 133.98M | 85.43M | 9.44M |
| Property-Plant & Equipment | 141.82M | 100.01M | 73.74M | 71.24M | 36.34M | 7.15M | 6.87M | 5.25M |
| Goodwill & Intangibles | 71.28M | 72.35M | 73.42M | 74.48M | 75.55M | 76.62M | 77.69M | n/a |
| Total Long-Term Assets | 230.67M | 182.42M | 151.75M | 160.93M | 113.28M | 86.55M | 85.16M | 5.64M |
| Total Assets | 2.56B | 2.06B | 811.93M | 737.99M | 567.4M | 220.53M | 170.59M | 15.08M |
| Account Payables | 54.43M | 61.79M | 21.31M | 14.06M | 12.61M | 11.4M | 5.24M | 3.35M |
| Deferred Revenue | n/a | n/a | 4.46M | 18.93M | 20.59M | 17.12M | 16.83M | n/a |
| Short-Term Debt | 12.87M | 7.37M | 13.55M | 12.43M | 3.67M | 200K | 147K | n/a |
| Other Current Liabilities | 96.61M | 74.69M | 22.67M | 21.51M | 18.78M | 14.33M | 8.34M | 4.25M |
| Total Current Liabilities | 163.91M | 143.85M | 61.98M | 18.93M | 47.18M | 43.05M | 30.55M | 7.6M |
| Long-Term Debt | 122.97M | 80.58M | 57.43M | 60.42M | 28.99M | n/a | n/a | n/a |
| Other Long-Term Liabilities | 3.86M | 7.97M | 301K | 634K | 632K | 2.4M | 2.77M | 2.95M |
| Total Long-Term Liabilities | 129.18M | 91.66M | 64.76M | 116.49M | 45.55M | 24.94M | 43.38M | 2.95M |
| Total Liabilities | 293.1M | 235.51M | 126.74M | 135.42M | 92.72M | 67.99M | 73.93M | 10.55M |
| Total Debt | 135.84M | 87.94M | 64.2M | 66.63M | 32.66M | 172K | 147K | n/a |
| Common Stock | 18K | 16K | 9K | 8K | 7K | n/a | 3K | 1K |
| Retained Earnings | -1.74B | -1.14B | -701.34M | -452.64M | -265.55M | -157.39M | -109.72M | -67.93M |
| Comprehensive Income | 1.32M | 544K | -1.78M | -376K | 116K | 74K | -3.62M | -2.18M |
| Shareholders Equity | 2.27B | 1.83B | 685.19M | 602.57M | 474.68M | 152.53M | 96.66M | 4.53M |
| Total Investments | 1.75B | 1.16B | 483.53M | 468.56M | 336.47M | 106.1M | 214K | n/a |